The motor unit number index (MUNIX) profile of patients with adult spinal muscular atrophy

  • Giorgia Querin
  • , Timothée Lenglet
  • , Rabab Debs
  • , Tanya Stojkovic
  • , Anthony Behin
  • , François Salachas
  • , Nadine Le Forestier
  • , Maria del Mar Amador
  • , Lucette Lacomblez
  • , Vincent Meininger
  • , Gaelle Bruneteau
  • , Pascal Laforêt
  • , Sophie Blancho
  • , Véronique Marchand-Pauvert
  • , Peter Bede
  • , Jean Yves Hogrel
  • , Pierre François Pradat

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: Objective of this study is the comprehensive characterisation of motor unit (MU) loss in type III and IV Spinal Muscular Atrophy (SMA) using motor unit number index (MUNIX), and evaluation of compensatory mechanisms based on MU size indices (MUSIX). Methods: Nineteen type III and IV SMA patients and 16 gender- and age-matched healthy controls were recruited. Neuromuscular performance was evaluated by muscle strength testing and functional scales. Compound motor action potential (CMAP), MUNIX and MUSIX were studied in the abductor pollicis brevis (APB), abductor digiti minimi (ADM), deltoid, tibialis anterior and trapezius muscles. A composite MUNIX score was also calculated. Results: SMA patients exhibited significantly reduced MUNIX values (p < 0.05) in all muscles, while MUSIX was increased, suggesting active re-innervation. Significant correlations were identified between MUNIX/MUSIX and muscle strength. Similarly, composite MUNIX scores correlated with disability scores. Interestingly, in SMA patients MUNIX was much lower in the ADM than in the ABP, a pattern which is distinctly different from that observed in Amyotrophic Lateral Sclerosis. Conclusions: MUNIX is a sensitive measure of MU loss in adult forms of SMA and correlates with disability. Significance: MUNIX evaluation is a promising candidate biomarker for longitudinal studies and pharmacological trials in adult SMA patients.

Original languageEnglish
Pages (from-to)2333-2340
Number of pages8
JournalClinical Neurophysiology
Volume129
Issue number11
DOIs
Publication statusPublished (in print/issue) - 1 Nov 2018

Funding

This study was supported by the Association Française contre les Myopathies (AFM) and the Institut pour la Recherche sur la Moelle épinière et l'Encéphale (IRME). The research leading to these results has also received funding from the program “Investissements d’avenir” ANR-10-IAIHU-06. Dr. Giorgia Querin, Dr. Timothée Lenglet, Dr. Anthony Behin, Dr. Tanya Stojkovic, Dr. François Salachas, Dr. Nadine Le Forestier, Dr. Maria del Mar Amador, Dr. Rabab Debs, Dr. Lucette Lacomblez, Prof. Vincent Meininger, Dr. Gaelle Brunetau, Prof. Pascal Laforêt, Sophie Blancho, Dr. Véronique Marchand-Pauvert, Dr. Jean-Yves Hogrel and Dr. Pierre-François Pradat report no disclosures. Dr. Peter Bede is supported by the Health Research Board (HRB – Ireland; HRB EIA-2017-019), the Irish Institute of Clinical Neuroscience IICN – Novartis Ireland Research Grant, and the Iris O'Brien Foundation Ireland.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Biomarkers
  • Motor unit loss
  • MUNIX
  • MUSIX
  • SMA type III
  • SMA type IV

Fingerprint

Dive into the research topics of 'The motor unit number index (MUNIX) profile of patients with adult spinal muscular atrophy'. Together they form a unique fingerprint.

Cite this